Negative and statistically significant correlations between CD28 expression and percentages of CD4+NKG2D+ T cells were observed in both cancer patients (Spearman ρ = -0.859; p < 0.001) and healthy controls (Spearman ρ = -0.522; p = 0.003). This evidence concerns the gene CD28 and cancer.